Xenetic Biosciences(XBIO) - 2025 FY - Earnings Call Transcript

Financial Data and Key Metrics Changes - The meeting reported that proxies were received for 961,887 of the 2,277,139 shares of common stock outstanding, representing approximately 42% of the total shares, which unfortunately does not constitute a quorum for business transactions [3]. Company Strategy and Development Direction - The company has adjourned the annual stockholders' meeting due to the lack of quorum, indicating a need for better engagement with shareholders to ensure future meetings can proceed as planned [4]. Other Important Information - The company will determine a new date and time to hold the 2025 annual stockholders' meeting, reflecting ongoing organizational and operational adjustments [4]. Q&A Session Summary - No questions or answers were recorded during this meeting as it was adjourned due to the lack of quorum, preventing any business transactions from taking place [3].